Skip to main content
OpenTrials

Clinical trial condition

Ewing Sarcoma

Explore clinical trials studying Ewing Sarcoma. Study availability and eligibility vary by location and protocol.

83 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Ewing Sarcoma trial results

Active, Not Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT04337177

Conditions
Disease Attributes, Ewing Sarcoma, Glioma, +26 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF, Mission Bay - Benioff Children's Hospital San Francisco, California, United States
  • Children's National Research Institute - Children's National Hospital Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

NCT02867592

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 142 locations
View Trial Details
Active, Not Recruiting

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

NCT06068075

Conditions
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

NCT06566092

Conditions
Ewing Sarcoma, Melanoma, Myosarcoma, +21 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

NCT05830084

Conditions
Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Queensland Children's Hospital Brisbane, Australia
  • Monash Children's Hospital Clayton, Australia
  • Royal Children's Hospital Parkville, Australia
  • Perth Children's Hospital Perth, Australia
View all 13 locations
View Trial Details

Related conditions